
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [GILD] Gilead Sciences, Inc.
Data updated 2025-Apr-29 (Tuesday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-Apr-29 Tuesday
Open | $105.68 | High | $107.17 +1.41% |
---|---|---|---|
Close | $104.21 | Low | $104.11 -1.49% |
Volume | 7.64 Million 1.15x | Volatility | 2.94% |
Change |
$-2.13
-2.00%
|
Streak | ↓ 1 days -2.00% |
20d SMA | $105.97 -1.7% | 50d SMA | $109.27 -4.6% | 100d SMA | $101.59 +2.6% | 200d SMA | $92.06 +13.2% |
RSI | 45 | MACD | 0.01 | ADX | 32.4 | Stochastic Oscillator | 76.8 68.1 |
CCI | -18.8 | ATR | 3.98 | OBV | 3.7 Billion | Chaikin A/D | 2.37 Billion |
Market Cap | 85.6 B | PEG Ratio | 0.42 | Trailing P/E | 15.3 | Forward P/E | 9.73 |
Price/Sales (ttm) | 3.18 | Price/Book (mrq) | 3.75 | EV/Revenue (ttm) | 3.81 | EV/EBITDA (ttm) | 9.84 |
% Held by Insiders | 0.09% | % Held by Institutions | 88.38% | Shares Short | 22.6 M | Shares Short (prior month) | 19.7 M |
Short Ratio | 3.06 | Short % of Outstanding | 1.81% | Short % of Float | 1.82% | Shares Short Change (mom) | +14.7% |
Revenue/Share (ttm) | $21.73 | Profit Margin (ttm) | 20.89% | Operating Margin (ttm) | 42.21% | EBITDA (ttm) | 12.5 B |
Diluted EPS (ttm) | $4.50 | Current Ratio (mrq) | 1.43 | Return on Assets (ttm) | 9.78% | Return on Equity (ttm) | 25.54% |
Qtr Earnings Growth (yoy) | -12.90% | Qtr Revenue Growth (yoy) | -3.70% | Operating Cash Flow (ttm) | 8.01 B | Free Cash Flow (ttm) | 8.79 B |
Choose view type
Daily Performance for Gilead Sciences, Inc.. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Gilead Sciences, Inc. up to close of 2025-Apr-29 at $104.21
1-month Performance Benchmarks for Gilead Sciences, Inc.:
Related to Gilead Sciences, Inc.
Information for Gilead Sciences, Inc.
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Dividend History : History of Dividend Yield
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Apr-29 on Google
SEC Reports : Quarterly reports around 2025-Apr-29 on SEC Edgar
Compare Gilead Sciences, Inc. with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Gilead Sciences, Inc.
Industry : Biotechnology industry performance which includes Gilead Sciences, Inc.